Pesquisas alternativas:
nerve » serve (Expandir a Pesquisa)
fuertes » fuerte (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
meng » men (Expandir a Pesquisa), ming (Expandir a Pesquisa)
nerve » serve (Expandir a Pesquisa)
fuertes » fuerte (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
meng » men (Expandir a Pesquisa), ming (Expandir a Pesquisa)
1
2
“... are the Bederson and Garcia scales, manual assessments scoring animals based on parameters ranked on a narrow scale...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“..., there are eight FDA approved disease modifying therapies for MS including: IFN-β-1a (Avonex, Rebif), IFN-β-1b...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Jehkonen, M., Laihosalo, M., Saunamäki, T., Koivisto, A-M., Dastidar, P., Ahonen, J-P.
Publicado em 2010
“... spontaneous recovery to survival in a homogenous patient group with first-ever RH stroke. METHODS: Fifty-one...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Artigo
5
“...Multiple sclerosis (MS) is a progressive immune-mediated neurodegenerative disease of human central...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... of restless legs syndrome (RLS) symptoms. Although gabapentin enacarbil is a pro-drug of gabapentin, its...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“..., but that it is particularly beneficial in patients with a diagnosis of tuberous sclerosis. Adrenocorticotropic hormone (ACTH...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Ruuskanen, E-I., Laihosalo, M., Kettunen, JE., Losoi, H., Nurmi, L., Koivisto, A-M., Dastidar, P., Ollikainen, J., Jehkonen, M.
Publicado em 2010
“... as a statistically significant predictor of discharge time in patients with moderate/severe stroke...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“...Eslicarbazepine acetate (ESL) is a novel antiepileptic drug indicated for the treatment of partial...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Russo, Anthony J
Publicado em 2014
“... and their receptors may play a role in the etiology of ASDs. Research has shown that epidermal growth factor receptor...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Marriott, James J.
Publicado em 2011
“... of using fingolimod as a first-line disease-modifying therapy in treatment-naïve relapsing-remitting...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... to create a gap in the delivery of care to meet the American Stroke Association guidelines in underserviced...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“...Attention deficit/hyperactivity disorder (ADHD) is a common disorder and a plethora of new data has...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“.... This is based on class-I evidence demonstrating significant seizure reduction in once daily dosing. Keppra-XR...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... sleep, has not been shown to improve symptoms of depression. A novel antidepressant, agomelatine...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“... medications to treat the symptoms of ADHD in adults. Based on the literature, increased doses are associated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Shell, William E., May, Lawrence A., Bullias, Debora H., Pavlik, Stephanie L., Silver, David S.
Publicado em 2012
“...-controlled, randomized trial compared (1) low dose trazodone, (2) Sentra PM, a neurotransmitter based medical...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Evidence-Based Pharmacotherapy for Pediatric Obsessive-Compulsive Disorder and Chronic Tic Disorders
Por De Nadai, Alessandro S., Storch, Eric A., McGuire, Joseph F., Lewin, Adam B., Murphy, Tanya K.
Publicado em 2011
“... agonists. The purpose of this review is to discuss the evidence base for pharmacotherapy with pediatric OCD...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... Leigh-like SLC19A3 gene defects of patients who died at 4 months of age with no response to a high dose...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Turón-Viñas, Eulàlia, Pineda, Mercè, Cusí, Victòria, López-Laso, Eduardo, del Pozo, Rebeca Losada, Gutiérrez-Solana, Luis González, Moreno, David Conejo, Sierra-Córcoles, Concha, Olabarrieta-Hoyos, Naiara, Madruga-Garrido, Marcos, Aguirre-Rodríguez, Javier, González-Álvarez, Verónica, O’Callaghan, Mar, Muchart, Jordi, Armstrong-Moron, Judith
Publicado em 2014
“... initiation factor (eIF2B). We have compiled a list of all the patients diagnosed with VWM in Spain; we found...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo